As experts in Artificial Intelligence (AI) and MRI technology, Maxwell Plus believe the future of healthcare firmly lies within this technology. Established in 2016, this Brisbane-based start-up is passionate about driving change towards personalised healthcare solutions.

Working towards a vision of post scarcity health care, Maxwell Plus is rethinking the identification, detection and diagnosis of diseases such as cancer. By combining machine learning with medical imaging, Maxwell Plus are working to make cancer diagnosis faster, more affordable and more accurate.

Due to the nature of cancer, there are cases every year, whether it be prostate, lung or breast, where early diagnosis is missed (false negatives) resulting in later diagnosis, and harsher treatments. There are also cases where individuals are misdiagnosed (false positives) and undergo unnecessary treatment which negatively impacts them through treatment side effects, out-of-pocket expenses, and reduced opportunity to work.

By training machine learning algorithms to read thousands of medical cases consisting of imaging, genetics, and histopathology, Maxwell’s AI can provide insights into personalised risk assessments and health monitoring. This aids in reducing the incidence of false negatives and false positives through improved accuracy in cancer detection.

Maxwell Plus is working to apply AI through Maxwell Plus Cloud to help clinicians diagnose disease and make health data and insights available to individuals with Maxwell Plus Health.

Maxwell Plus is also working with a number of global partners including University College London (United Kingdom), St Vincent’s/Garven (Australia) and Veterans Affairs (United State of America).